{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:28:46Z","timestamp":1791080926005,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3196,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Serum amyloid A (SAA) is an acute phase protein produced by the liver. SAA concentration increases markedly in the serum following inflammation and infection. Large increases in SAA concentration during the acute phase response suggest that SAA has a beneficial role in host defense. This study sought to determine the effect of SAA on hepatitis C virus (HCV) infectivity using retroviral particles pseudotyped with HCV envelope glycoproteins (HCVpp) and the recently developed cell culture system for HCV (HCVcc). SAA inhibited HCVpp and HCVcc infection in a dose-dependent manner by affecting an early step of the virus life cycle. Further characterization with HCVpp indicated that SAA blocks virus entry by interacting with the viral particle. In addition, the antiviral activity of SAA was strongly reduced when high-density lipoproteins (HDL) were coincubated with SAA. However, HDL had only a slight effect on the antiviral activity of SAA when HCVpp was first preincubated with SAA. Furthermore, analyses of SAA in sera of chronic HCV patients revealed the presence of variable levels of SAA with abnormally elevated concentrations in some cases. However, no obvious clinical correlation was found between SAA levels and HCV viral loads.<\/jats:bold>\n                                 <jats:bold>\n                                    In conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>, our data demonstrate an antiviral activity for SAA and suggest a tight relationship between SAA and HDL in modulating HCV infectivity.<\/jats:bold>\n                                 <jats:bold>\n                                    Supplementary material for this article can be found on the HEPATOLOGY website\n                                 <\/jats:bold> (http:\/\/interscience.wiley.com\/jpages\/0270-9139\/suppmat\/index.html).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21406","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T21:03:34Z","timestamp":1164747814000},"page":"1626-1634","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":82,"title":["Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system"],"prefix":"10.1097","volume":"44","author":[{"given":"Muriel","family":"Lavie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Voisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc","family":"Vu-Dac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Duverlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Czeslaw","family":"Wychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20241201","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C pseudoparticles containing functional E1E2 envelope protein complexes.","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"R2-34-20241201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","article-title":"Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins.","volume":"546","author":"Drummer","year":"2003","journal-title":"FEBS Lett"},{"key":"R3-34-20241201","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pHdependent cell entry of pseudotyped retroviral particles.","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-34-20241201","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture.","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"R5-34-20241201","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"R6-34-20241201","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro.","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-34-20241201","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041433-200406000-00008","article-title":"Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids.","volume":"15","author":"Connelly","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R8-34-20241201","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"R9-34-20241201","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/vir.0.81646-0","article-title":"Hepatitis C virus entry: potential receptors and their biological functions.","volume":"87","author":"Cocquerel","year":"2006","journal-title":"J Gen Virol"},{"key":"R10-34-20241201","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between the hypervariable region 1 of the HCV E2 glycoprotein, the scavenger receptor BI and HDL promotes both enhancement of infection and protection against neutralizing antibodies.","volume":"79","author":"Bartosch","year":"2005","journal-title":"J Virol"},{"key":"R11-34-20241201","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for crossgenotype neutralization of hepatitis C virus pseudoparticles and enhancement of infectivity by apolipoprotein C1.","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-34-20241201","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1074\/jbc.M411600200","article-title":"High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.","volume":"280","author":"Voisset","year":"2005","journal-title":"J Biol Chem"},{"key":"R13-34-20241201","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1074\/jbc.M405009200","article-title":"Serum amyloid A binding to CLA1 (CD36 and LIMPII analogous1) mediates serum amyloid A proteininduced activation of ERK12 and p38 mitogenactivated protein kinases.","volume":"280","author":"Baranova","year":"2005","journal-title":"J Biol Chem"},{"key":"R14-34-20241201","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1074\/jbc.M411555200","article-title":"Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake.","volume":"280","author":"Cai","year":"2005","journal-title":"J Biol Chem"},{"key":"R15-34-20241201","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acutephase reactant.","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur J Biochem"},{"key":"R16-34-20241201","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/jvi.68.10.6147-6160.1994","article-title":"Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.","volume":"68","author":"Dubuisson","year":"1994","journal-title":"J Virol"},{"key":"R17-34-20241201","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.73.8.6235-6244.1999","article-title":"Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.","volume":"73","author":"Flint","year":"1999","journal-title":"J Virol"},{"key":"R18-34-20241201","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/j.1460-2075.1986.tb04306.x","article-title":"Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface.","volume":"5","author":"Kreis","year":"1986","journal-title":"EMBO J"},{"key":"R19-34-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-1-4831-9942-9.50008-5","article-title":"Practical methods for plasma lipoprotein analysis.","volume":"6","author":"Hatch","year":"1968","journal-title":"Adv Lipid Res"},{"key":"R20-34-20241201","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"key":"R21-34-20241201","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JVI.78.6.2994-3002.2004","article-title":"Characterization of functional hepatitis C virus envelope glycoproteins.","volume":"78","author":"Op De Beeck","year":"2004","journal-title":"J Virol"},{"key":"R22-34-20241201","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hep.20542","article-title":"Characterization of hostrange and cell entry properties of hepatitis C virus of major genotypes and subtypes.","volume":"41","author":"Lavillette","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R23-34-20241201","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2001-11-0042","article-title":"Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34 cells derived from human and nonhuman primates.","volume":"100","author":"Sandrin","year":"2002","journal-title":"Blood"},{"key":"R24-34-20241201","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.80.6.2832-2841.2006","article-title":"Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus.","volume":"80","author":"Rouille","year":"2006","journal-title":"J Virol"},{"key":"R25-34-20241201","doi-asserted-by":"crossref","first-page":"35890","DOI":"10.1074\/jbc.M505685200","article-title":"Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor BI.","volume":"280","author":"van der Westhuyzen","year":"2005","journal-title":"J Biol Chem"},{"key":"R26-34-20241201","doi-asserted-by":"crossref","first-page":"15422","DOI":"10.1073\/pnas.222421399","article-title":"Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SRBI.","volume":"99","author":"Nieland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-34-20241201","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1128\/JVI.78.13.6875-6882.2004","article-title":"Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.","volume":"78","author":"Flint","year":"2004","journal-title":"J Virol"},{"key":"R28-34-20241201","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcv.2004.03.009","article-title":"TaqMan amplification system with an internal positive control for HCV RNA quantitation.","volume":"31","author":"Castelain","year":"2004","journal-title":"J Clin Virol"},{"key":"R29-34-20241201","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acutephase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"R30-34-20241201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0167-5699(94)90138-4","article-title":"The major acute phase reactants: Creactive protein, serum amyloid P component and serum amyloid A protein.","volume":"15","author":"Steel","year":"1994","journal-title":"Immunol Today"},{"key":"R31-34-20241201","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0022-2275(20)37453-8","article-title":"Apolipoproteinmediated removal of cellular cholesterol and phospholipids.","volume":"37","author":"Oram","year":"1996","journal-title":"J Lipid Res"},{"key":"R32-34-20241201","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1074\/jbc.M500490200","article-title":"Serum amyloid A protein binds to outer membrane protein A of gramnegative bacteria.","volume":"280","author":"HariDass","year":"2005","journal-title":"J Biol Chem"},{"key":"R33-34-20241201","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","article-title":"Serum amyloid A is an innate immune opsonin for Gramnegative bacteria.","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"R34-34-20241201","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","article-title":"A soluble receptor for interleukin1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.","volume":"71","author":"Alcami","year":"1992","journal-title":"Cell"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21406","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200612000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:11:50Z","timestamp":1733058710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200612000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21406","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}